NCT02317705 Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02312167 Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE) Status COMPLETED Phase NA
NCT02307500 Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy Status COMPLETED Phase PHASE2
NCT02298855 Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer. Status COMPLETED Phase NA
NCT02288676 DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics Status RECRUITING Phase N/A
NCT02287519 Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention Status COMPLETED Phase NA
NCT02278783 Phase 2 Trial of Regorafenib in Patients With Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer Status TERMINATED Phase PHASE2
NCT02269293 Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers Status COMPLETED Phase PHASE1
NCT02262455 Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02247323 Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125 Status UNKNOWN Phase N/A
NCT02237690 Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer Status COMPLETED Phase PHASE1
NCT02221076 Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures. Status COMPLETED Phase NA
NCT02218502 Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal Masses Status TERMINATED Phase NA
NCT02203513 A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer Status TERMINATED Phase PHASE2
NCT02188550 Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer Status UNKNOWN Phase PHASE2
NCT02179515 Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) Status COMPLETED Phase PHASE1